MENU
ANNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Annexon (ANNX) Earnings Date & Reports
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye... Show more
A.I. Advisor
published Earnings
ANNX is expected to report earnings to rise 5.09% to -24 cents per share on August 17
Q2'26
Est.
$-0.24
Q1'26
Beat
by $0.05
Q4'25
Beat
by $0.04
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.02
The last earnings report on May 07 showed earnings per share of -23 cents, beating the estimate of -28 cents. With 2.92M shares outstanding, the current market capitalization sits at 861.81M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain
Industry Biotechnology
Profile
Details
Industry
N/A
Address
1400 Sierra Point Parkway
Phone
+1 650 822-5500
Employees
96
Web
https://www.annexonbio.com